Lv7
4580 积分 2021-12-06 加入
Combination of the Human Anti-CD30 Antibody 5F11 with Cytostatic Drugs Enhances Its Antitumor Activity against Hodgkin and Anaplastic Large Cell Lymphoma Cell Lines
14天前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
16天前
已完结
Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus
16天前
已完结
Trends in the drug target landscape for autoimmune diseases
1个月前
已完结
CD34-selected stem cell boost was an effective treatment for refractory poor hematopoietic reconstitution after haploidentical hematopoietic stem cell transplantation
1个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
1个月前
已完结
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure
1个月前
已完结
Trop2-Targeted Molecular Imaging in Solid Tumors: Current Advances and Future Outlook
1个月前
已完结
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
1个月前
已完结
Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
1个月前
已完结
Interview with Carlos Caldas
皖公网安备34019202002308
